Population pharmacokinetics of tofacitinib in patients with psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Pharmacology and Therapeutics"
DOI: 10.5414/cp203516
Abstract: Objective: Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This analysis characterized the pharmacokinetics (PK) of tofacitinib in adult patients with active PsA and evaluated the impact of covariates… read more here.
Keywords: population pharmacokinetics; patients active; pharmacokinetics tofacitinib; active psa ... See more keywords